Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Equity (2022 - 2025)

Historic Return on Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Q3 2025 value amounting to 104.3%.

  • Molecular Partners Ag's Return on Equity rose 3155300.0% to 104.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 104.3%, marking a year-over-year increase of 3155300.0%. This contributed to the annual value of 341.38% for FY2024, which is 259100.0% down from last year.
  • Molecular Partners Ag's Return on Equity amounted to 104.3% in Q3 2025, which was up 3155300.0% from 95.4% recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Return on Equity ranged from a high of 1007168.63% in Q1 2022 and a low of 112947.83% during Q4 2024
  • For the 4-year period, Molecular Partners Ag's Return on Equity averaged around 87657.03%, with its median value being 141.33% (2023).
  • Per our database at Business Quant, Molecular Partners Ag's Return on Equity tumbled by 2000000000bps in 2023 and then skyrocketed by 927224100bps in 2025.
  • Quarter analysis of 4 years shows Molecular Partners Ag's Return on Equity stood at 655377.79% in 2022, then crashed by -112bps to 77564.09% in 2023, then crashed by -46bps to 112947.83% in 2024, then skyrocketed by 100bps to 104.3% in 2025.
  • Its Return on Equity stands at 104.3% for Q3 2025, versus 95.4% for Q2 2025 and 55.39% for Q1 2025.